1. Home
  2. RFL vs JSPR Comparison

RFL vs JSPR Comparison

Compare RFL & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • JSPR
  • Stock Information
  • Founded
  • RFL 2017
  • JSPR 2018
  • Country
  • RFL United States
  • JSPR United States
  • Employees
  • RFL N/A
  • JSPR N/A
  • Industry
  • RFL Real Estate
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RFL Finance
  • JSPR Health Care
  • Exchange
  • RFL Nasdaq
  • JSPR Nasdaq
  • Market Cap
  • RFL 54.4M
  • JSPR 47.6M
  • IPO Year
  • RFL N/A
  • JSPR N/A
  • Fundamental
  • Price
  • RFL $1.44
  • JSPR $2.85
  • Analyst Decision
  • RFL
  • JSPR Buy
  • Analyst Count
  • RFL 0
  • JSPR 12
  • Target Price
  • RFL N/A
  • JSPR $30.78
  • AVG Volume (30 Days)
  • RFL 58.4K
  • JSPR 289.7K
  • Earning Date
  • RFL 06-11-2025
  • JSPR 08-13-2025
  • Dividend Yield
  • RFL N/A
  • JSPR N/A
  • EPS Growth
  • RFL N/A
  • JSPR N/A
  • EPS
  • RFL N/A
  • JSPR N/A
  • Revenue
  • RFL $732,000.00
  • JSPR N/A
  • Revenue This Year
  • RFL N/A
  • JSPR N/A
  • Revenue Next Year
  • RFL N/A
  • JSPR N/A
  • P/E Ratio
  • RFL N/A
  • JSPR N/A
  • Revenue Growth
  • RFL 35.56
  • JSPR N/A
  • 52 Week Low
  • RFL $1.28
  • JSPR $2.27
  • 52 Week High
  • RFL $3.19
  • JSPR $26.05
  • Technical
  • Relative Strength Index (RSI)
  • RFL 31.57
  • JSPR 40.39
  • Support Level
  • RFL $1.66
  • JSPR $2.81
  • Resistance Level
  • RFL $1.67
  • JSPR $3.14
  • Average True Range (ATR)
  • RFL 0.09
  • JSPR 0.21
  • MACD
  • RFL -0.03
  • JSPR 0.08
  • Stochastic Oscillator
  • RFL 0.00
  • JSPR 57.97

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: